News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
878,651 Results
Type
Article (88507)
Company Profile (814)
Press Release (789298)
Multimedia
Podcasts (224)
Webinars (34)
Section
Business (233470)
Career Advice (4156)
Deals (39938)
Drug Delivery (172)
Drug Development (91591)
Employer Resources (207)
FDA (18500)
Job Trends (17465)
News (398448)
Policy (40014)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (37)
Allergies (181)
Alliances (56986)
ALS (213)
Alzheimer's disease (1908)
Antibody-drug conjugate (ADC) (480)
Approvals (18769)
Artificial intelligence (778)
Autoimmune disease (280)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (233)
Biotechnology (486)
Bladder cancer (193)
Brain cancer (78)
Breast cancer (758)
Cancer (5995)
Cardiovascular disease (516)
Career advice (3587)
Career pathing (48)
CAR-T (348)
CDC (73)
Celiac Disease (2)
Cell therapy (962)
Cervical cancer (47)
Clinical research (78199)
Collaboration (2205)
Company closure (7)
Compensation (1372)
Complete response letters (100)
COVID-19 (3022)
CRISPR (115)
C-suite (1138)
Cystic fibrosis (162)
Data (7714)
Decentralized trials (3)
Denatured (84)
Depression (183)
Dermatology (73)
Diabetes (614)
Diagnostics (7472)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (384)
Drug pricing (241)
Drug shortages (39)
Duchenne muscular dystrophy (293)
Earnings (101574)
Editorial (75)
Employer branding (25)
Employer resources (174)
Events (137117)
Executive appointments (1138)
FDA (22255)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1805)
Gene editing (252)
Generative AI (85)
Gene therapy (787)
GLP-1 (1229)
Government (5530)
Grass and pollen (8)
Guidances (408)
Healthcare (21065)
HIV (86)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (337)
Immuno-oncology (98)
Indications (171)
Infectious disease (3391)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (290)
Interviews (818)
IPO (17982)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (109)
Layoffs (673)
Leadership (48)
Legal (10170)
Liver cancer (107)
Longevity (33)
Lung cancer (797)
Lymphoma (431)
Machine learning (62)
Management (66)
Manufacturing (1088)
MASH (197)
Medical device (15195)
Medtech (15288)
Mergers & acquisitions (23177)
Metabolic disorders (1645)
mRNA (233)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (448)
Neuropsychiatric disorders (121)
Neuroscience (3505)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (76)
Obesity (800)
Opinion (364)
Ovarian cancer (214)
Pain (265)
Pancreatic cancer (299)
Parkinson's disease (380)
Partnered (39)
Patents (604)
Patient recruitment (663)
Peanut (66)
People (67610)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24161)
Phase 2 (33959)
Phase 3 (25548)
Pipeline (8008)
Policy (379)
Postmarket research (3557)
Preclinical (10877)
Press Release (72)
Prostate cancer (301)
Psychedelics (65)
Radiopharmaceuticals (347)
Rare diseases (1154)
Real estate (7452)
Recruiting (81)
Regulatory (29920)
Reports (76)
Research institute (2761)
Resumes & cover letters (653)
Rett syndrome (36)
RNA editing (25)
RSV (98)
Schizophrenia (186)
Series A (304)
Series B (221)
Service/supplier (30)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (187)
Sponsored (54)
Startups (4355)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (137)
Vaccines (1251)
Venture capital (116)
Weight loss (553)
Women's health (127)
Worklife (24)
Date
Today (187)
Last 7 days (723)
Last 30 days (2984)
Last 365 days (33207)
2026 (10983)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57665)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1295)
Alabama (100)
Alaska (7)
Arizona (381)
Arkansas (16)
Asia (52001)
Australia (9143)
California (13260)
Canada (3761)
China (1401)
Colorado (573)
Connecticut (586)
Delaware (403)
Europe (119792)
Florida (1969)
Georgia (433)
Hawaii (4)
Idaho (69)
Illinois (1141)
India (97)
Indiana (622)
Iowa (25)
Japan (532)
Kansas (138)
Kentucky (53)
Louisiana (45)
Maine (87)
Maryland (1624)
Massachusetts (9683)
Michigan (401)
Minnesota (745)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (145)
New Hampshire (92)
New Jersey (3551)
New Mexico (33)
New York (3506)
North Carolina (1801)
North Dakota (10)
Northern California (6506)
Ohio (408)
Oklahoma (26)
Oregon (55)
Pennsylvania (2644)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5174)
Tennessee (211)
Texas (2139)
United States (47635)
Utah (396)
Vermont (1)
Virginia (338)
Washington D.C. (88)
Washington State (1096)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
There are 878,651 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
April 28, 2026
·
7 min read
Press Releases
Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies
April 28, 2026
·
4 min read
Press Releases
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
April 28, 2026
·
11 min read
Press Releases
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
April 28, 2026
·
2 min read
Mergers & acquisitions
AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B
AbbVie is setting up a shot to buy Kestrel Therapeutics down the line, as the biotech doses patients in a Phase 1 trial for the oral pan-KRAS inhibitor KST-6051 in solid tumors.
April 28, 2026
·
1 min read
·
Annalee Armstrong
Obesity
Boehringer, Zealand’s obesity drug ‘more akin’ to Novo’s Wegovy in Phase 3
Topline Phase 3 results of survodutide—licensed to Boehringer Ingelheim from Zealand Pharma—are more comparable to Novo Nordisk’s Wegovy than to Eli Lilly’s Zepbound, William Blair analysts said on Tuesday.
April 28, 2026
·
2 min read
·
Heather McKenzie
Cancer
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ Trodelvy showed promising results, while a complex combination by Agenus and MiNK Therapeutics failed to elicit an overall response.
April 28, 2026
·
5 min read
·
Andrea Park
Press Releases
Annovis Publishes Phase 2/3 Alzheimer’s Trial Results in Nature Portfolio
April 28, 2026
·
4 min read
Press Releases
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
April 28, 2026
·
7 min read
Press Releases
Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment
April 28, 2026
·
3 min read
1 of 87,866
Next
